Emerging biomarkers and molecular targets for precision medicine in cervical cancer

P Garg, M Krishna, AR Subbalakshmi… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Cervical cancer remains a significant global health burden, necessitating innovative
approaches for improved diagnostics and personalized treatment strategies. Precision …

Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved

RF Lengkey, RS Soetadji… - World Academy of …, 2024 - spandidos-publications.com
Gynecological cancers constitute a significant health burden for females worldwide, with
cervical, endometrial and ovarian cancer being the most common types. The renin …

Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers

X Zhou, Y Wang, M Bao, Y Chu, R Liu, Q Chen… - Applied Microbiology …, 2024 - Springer
Cervical cancer is a major global health concern, characterized by its high incidence and
mortality rates. The detection of tumor markers is crucial for managing cancer, making …

[HTML][HTML] Связь полиморфизма rs2010963 гена VEGFА с развитием и прогрессированием рака шейки матки

АВ Рогалев, МС Кишеня, СВ Пищулина… - Альманах …, 2023 - cyberleninka.ru
Актуальность. Рак шейки матки (РШМ)–наиболее распространенная форма
злокачественных новообразований женской половой системы. В России …

Association of VEGFA gene rs2010963 polymorphism with cervical cancer and its progression

AV Rogalev, MS Kishenya, SV Pishchulina… - Almanac of Clinical …, 2023 - almclinmed.ru
Background: Cervical cancer is the most common type of female genital malignancies. In
Russia, its incidence is 17 to 19 cases per 100,000 of female population. Cervical cancer is …